ALKEM LABORATORIES
|
The Current P/E Ratio of ALKEM LABORATORIES is 26.31.
Share Price | ₹4,833.8 | Apr 01,2025 |
Market Cap | ₹57,812.2 Cr | |
Earnings-TTM | ₹2,197.5 Cr | TTM-Consolidated Results |
Price/Earnings | 26.31x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ALKEM LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹57,812.2 Cr] as on Apr 01,2025
(/) Earnings [ ₹2,197.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 26.31x ]
Thus, for ALKEM LABORATORIES , the investors are currently willing to pay 26.31 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALKEM LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALKEM LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of ALKEM LABORATORIES
PE Ratio Performance Analysis for ALKEM LABORATORIES
- ALKEM LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 29.21x.
- ALKEM LABORATORIES 's operated at median p/e ratio of 26.28x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALKEM LABORATORIES 's p/e ratio peaked in Mar2023 at 41.27x.
- ALKEM LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 20.91x.
How does ALKEM LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ALKEM LABORATORIES | 2,197.47 | 26.31 | 57,812.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 35.45 | 407,155.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 71.26 | 147,295.0 |
CIPLA LTD | 5,000.43 | 23.33 | 116,664.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 57.83 | 107,678.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 17.71 | 96,162.6 |
MANKIND PHARMA LTD | 2,050.73 | 49.43 | 101,358.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.23 | 88,297.0 |
LUPIN LTD | 2,892.10 | 30.88 | 89,322.4 |
AUROBINDO PHARMA LTD | 3,500.25 | 18.83 | 65,912.3 |
ABBOTT INDIA LTD | 1,334.46 | 48.26 | 64,397.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALKEM LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.71x |
Max industry PE | 71.26x |
Median industry PE | 30.88x |
Average industry PE | 36.23x |
You may also like the below Video Courses